Global Custom Antibody Market Report Segmented by Type (Monoclonal, Polyclonal, Recombinant), Service (Development, Production, Purification, Fragmentation, Labelling), Source (Mice, Rabbit), Application (Oncology, Neurology, Stem Cells), Forecast to 2030
The custom antibody market is set to witness a CAGR of ~10% during the forecast period. The market growth is primarily driven by expanding R&D activities, increasing demand for customized antibodies, growing adoption of targeted therapeutics, and advancements in antibody engineering and production technologies. However, the high costs associated with development and the time-intensive nature of antibody generation present challenges that may slow market adoption. To learn more about the research report, download a sample report.
Report Overview
Custom antibodies are indispensable tools used by researchers and clinicians in life science research, medicine and diagnostics. These antibodies are designed in laboratories to identify and target a specific antigen of interest with high accuracy and precision that may not be addressed by commercially available antibodies. Antigen synthesis, serum collection, animal immunization (usually in rabbits, mice, or goats), and purification are some of the procedures which are used to produce custom antibodies.
To learn more about this report, download the PDF brochure
Targeted therapeutics drive growth in the custom antibody market
The key factor propelling the custom antibody market growth is the increasing demand for precision medicine and targeted therapeutics. With the growing number of R&D activities and better understanding of the molecular basis of complex diseases like cancer, autoimmune disorders, and infectious diseases, researchers need highly specific antibodies to identify and manipulate disease-related proteins. For instance, in June 2025, BioNTech and Bristol Myers Squibb signed a global collaboration to co-develop and co-commercialize BNT327, BioNTech’s PD‑L1 × VEGF‑A next-generation bispecific antibody for multiple solid tumor types.
Custom antibodies have a specific ability to bind precisely to unique epitopes, which can improve the detection in diagnostics and enhance efficacy in therapeutic applications. Additionally, biotech and pharma companies are investing more in custom antibody production to support the development of ADCs (antibody-drug conjugates) and other advanced biologics. For example, in December 2022, Merck announced an exclusive license and collaboration agreement with Kelun-Biotech to co-develop seven investigational preclinical antibody-drug conjugates (ADCs) for cancer treatment. This trend not only fuels market demand but also expands the applications of custom antibodies.
Technological innovations and collaborations boost custom antibody efficiency
In the evolving landscape of biotechnology, custom antibodies have emerged as an invaluable tool, propelling technological advancements in the diagnostic and therapeutic areas. One such notable innovation is the use of custom antibodies in phage display technology. This method allows scientists to rapidly screen billions of antibody variants and identify those with optimal binding to a specific target antigen.
Unlike other methods, this method has gained widespread adoption in industry and academic research, as it enhances the speed, scalability, and ability to produce tailored antibodies, which are significant for therapeutic applications. For instance,
- In December 2024, Antibody Solutions received approval to become a CRO for Levena’s Singularity™ SAPIEN™ Mouse platform, a transgenic animal model which allows researchers to generate high-affinity, human-derived antibodies more efficiently for both therapeutic and diagnostic applications
- In March 2024, Sino Biological, Inc. announced a collaboration with Rapid Novor, Inc. Under this agreement, Sino Biological leveraged Rapid Novors' REmAb monoclonal antibody (mAb) sequencing platform alongside its custom antibody development and production services, providing a seamless pipeline from antibody discovery to delivery
The increasing collaborations among biotech companies and research organizations has improve antibody performance and making the development process more efficient and reproducible. With the growing number of technological innovations, the barrier to entry for high-quality custom antibody production is being lowered, making it more accessible for a broader range of users in the research and diagnostics field.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global custom antibody market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories, Inc; Creative Biolabs; Merck KGaA; Agilent Technologies Inc; GenScript; Laboratory Corporation of America; Danaher Corporation; Kaneka Eurogentec S.A.; Bio-Techne; and Sino Biological, Inc., among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~10% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Type, Service, Source, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories, Inc; Creative Biolabs; Merck KGaA; Agilent Technologies Inc; GenScript; Laboratory Corporation of America; Danaher Corporation; Kaneka Eurogentec S.A.; Bio-Techne; and Sino Biological, Inc. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Custom Antibody Market Segmentation
This report by Medi-Tech Insights provides the size of the global custom antibody market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type, service, source, application, and end-user.
Market Size & Forecast (2023-2030), By Type, USD Million
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
Market Size & Forecast (2023-2030), By Service, USD Million
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labelling
Market Size & Forecast (2023-2030), By Source, USD Million
- Mice
- Rabbit
- Others
Market Size & Forecast (2023-2030), By Application, USD Million
- Oncology
- Infectious Diseases
- Neurology
- Stem cells
- Immunology
- Cardiovascular Diseases
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals & Clinics
- Academic & Research Institutes
- CRO
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the custom antibody market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the custom antibody market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Custom Antibody Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Growing demand for personalized medicine
- Rising investment in antibody-based drug discovery
- Expansion of proteomics and genomics research
- Increasing use of antibodies in diagnostic tools
- Surge in CRO and academic research collaborations
- Advancements in antibody engineering and production technologies
- Restraints
- High cost and time-consuming development process
- Regulatory and ethical challenges in animal-based antibody production
- Limited reproducibility and quality issues in small-scale production
- Opportunities
- Demand for high-affinity recombinant antibodies
- Increasing focus on rare and orphan disease research
- Growth in outsourcing of antibody development
- Key Market Trends
- Adoption of phage display and affinity maturation
- Rising demand for antibody-drug conjugates (ADCs)
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Custom Antibody Market Size & Forecast (2023-2030), By Type, USD Million
- Introduction
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
- Global Custom Antibody Market Size & Forecast (2023-2030), By Service, USD Million
- Introduction
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation & Labelling
- Global Custom Antibody Market Size & Forecast (2023-2030), By Source, USD Million
- Introduction
- Mice
- Rabbit
- Others
- Global Custom Antibody Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Oncology
- Infectious Diseases
- Neurology
- Stem cells
- Immunology
- Cardiovascular Diseases
- Others
- Global Custom Antibody Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals & Clinics
- Academic & Research Institutes
- CRO
- Others
- Global Custom Antibody Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Custom Antibody Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Custom Antibody Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Custom Antibody Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Custom Antibody Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Custom Antibody Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Type (USD Million)
- Market Size & Forecast, By Service (USD Million)
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Thermo Fisher Scientific Inc.
- Abcam plc
- Bio-Rad Laboratories, Inc
- Creative Biolabs
- Merck KGaA
- Agilent Technologies Inc
- GenScript
- Laboratory Corporation of America
- Danaher Corporation
- Kaneka Eurogentec S.A.
- Bio-Techne
- Sino Biological, Inc.
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Academic & Research Institutes and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
